BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2021 10:33:58 AM | Browse: 395 | Download: 673
 |
Received |
|
2021-03-22 09:24 |
|
Peer-Review Started |
|
2021-03-22 09:25 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-14 03:24 |
|
Revised |
|
2021-06-27 22:30 |
|
Second Decision |
|
2021-08-30 03:28 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-08-30 08:54 |
|
Articles in Press |
|
2021-08-30 08:54 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-09-10 09:29 |
|
Publish the Manuscript Online |
|
2021-09-15 10:33 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Hematology |
| Manuscript Type |
Minireviews |
| Article Title |
Primary gastric non-Hodgkin lymphomas: Recent advances regarding disease pathogenesis and treatment
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Michael D Diamantidis, Maria Papaioannou and Evdoxia Hatjiharissi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Evdoxia Hatjiharissi, MD, PhD, N/A, N/A, Division of Hematology, First Department of Internal Medicine, AHEPA General Hospital, Aristotle University of Thessaloniki, St. Kiriakidis 1, Thessaloniki 54636, Greece. ehatjiharissi@gmail.com |
| Key Words |
Primary gastric lymphoma; Extranodal non-Hodgkin’s lymphoma; Diffuse large B-cell lymphoma; Mucosa-associated lymphoid tissue; Immunochemotherapy; Rituximab-cyclophosphamide doxorubicin vincristine prednisone |
| Core Tip |
A few small, heterogeneous, retrospective studies have attempted to determine the optimal treatment for gastric diffuse large B-cell lymphoma, investigating the role of chemotherapy +/- rituximab, surgery and radiation in patient outcomes. Our retrospective research suggests that a better outcome is observed for these patients after the introduction of immunochemotherapy (rituximab-cyclophosphamide doxorubicin vincristine prednisone). Because statistical analysis might differ among various studies, it is crucial to correctly define the terms freedom from progression and lymphoma-specific survival. The latter provides information on whether the patients died from lymphoma or from other causes. |
| Publish Date |
2021-09-15 10:33 |
| Citation |
Diamantidis MD, Papaioannou M, Hatjiharissi E. Primary gastric non-Hodgkin lymphomas: Recent advances regarding disease pathogenesis and treatment . World J Gastroenterol 2021; 27(35): 5932-5945 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i35/5932.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i35.5932 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
